Sailish Honap

2.5k total citations · 3 hit papers
59 papers, 1.3k citations indexed

About

Sailish Honap is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Sailish Honap has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Genetics, 34 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Sailish Honap's work include Inflammatory Bowel Disease (48 papers), Microscopic Colitis (29 papers) and Biosimilars and Bioanalytical Methods (7 papers). Sailish Honap is often cited by papers focused on Inflammatory Bowel Disease (48 papers), Microscopic Colitis (29 papers) and Biosimilars and Bioanalytical Methods (7 papers). Sailish Honap collaborates with scholars based in United Kingdom, France and Canada. Sailish Honap's co-authors include Laurent Peyrin‐Biroulet, Catherine Le Berre, Silvio Danese, Peter M. Irving, Mark Samaan, Susanna Meade, Laurent Peyrin-Biroulet, Vipul Jairath, Raphael P. Luber and Richard Pollok and has published in prestigious journals such as The Lancet, Gastroenterology and Nature Reviews Drug Discovery.

In The Last Decade

Sailish Honap

49 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ulcerative colitis

2023 784 citations Sailish Honap, Laurent Peyrin‐Biroulet et al. profile →
Navigating the complexities of drug development for inflammatory bowel disease

2024 47 citations Sailish Honap, Vipul Jairath et al. profile →
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies

2024 37 citations Sailish Honap, Laurent Peyrin-Biroulet et al. Journal of Crohn s and Colitis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sailish Honap United Kingdom	14	669	418	360	253	240	59	1.3k
Guilherme Piovezani Ramos United States	14	500 0.7×	411 1.0×	326 0.9×	299 1.2×	229 1.0×	54	1.2k
Jean‐Marie Reimund France	19	480 0.7×	362 0.9×	319 0.9×	262 1.0×	264 1.1×	58	1.4k
Priyadarshini Loganathan United States	9	524 0.8×	217 0.5×	397 1.1×	270 1.1×	138 0.6×	40	1.1k
Mirabella Zhao Denmark	12	727 1.1×	219 0.5×	471 1.3×	362 1.4×	155 0.6×	26	1.1k
Katarzyna Neubauer Poland	21	341 0.5×	260 0.6×	219 0.6×	196 0.8×	221 0.9×	50	975
Marisa Iborra Spain	18	640 1.0×	434 1.0×	405 1.1×	246 1.0×	292 1.2×	61	1.3k
Jiaming Qian China	13	259 0.4×	423 1.0×	164 0.5×	211 0.8×	233 1.0×	57	988
Serge Dionne Canada	17	351 0.5×	285 0.7×	252 0.7×	143 0.6×	244 1.0×	28	1.1k
Gary R. Lichtenstein United States	24	1.1k 1.7×	221 0.5×	735 2.0×	405 1.6×	441 1.8×	118	2.0k
Yasuhiko Maruyama Japan	15	515 0.8×	157 0.4×	343 1.0×	405 1.6×	133 0.6×	40	1.2k

Countries citing papers authored by Sailish Honap

Since Specialization

Citations

This map shows the geographic impact of Sailish Honap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sailish Honap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sailish Honap more than expected).

Fields of papers citing papers by Sailish Honap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sailish Honap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sailish Honap. The network helps show where Sailish Honap may publish in the future.

Co-authorship network of co-authors of Sailish Honap

This figure shows the co-authorship network connecting the top 25 collaborators of Sailish Honap. A scholar is included among the top collaborators of Sailish Honap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sailish Honap. Sailish Honap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Honap, Sailish, et al.. (2025). Building a healthcare data warehouse: considerations, opportunities, and challenges. Frontiers in Digital Health. 7. 1691142–1691142.

Shields, Naomi N., et al.. (2025). Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights. Biomedicines. 13(11). 2655–2655.

Honap, Sailish, et al.. (2025). Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease. Clinical and Experimental Gastroenterology. Volume 18. 233–249.

Jouzeau, Jean‐Yves, David Moulin, Patrick Netter, et al.. (2025). Advanced combination therapy in inflammatory bowel disease. Joint Bone Spine. 92(5). 105922–105922. 1 indexed citations

Vuyyuru, Sudheer K., Yuhong Yuan, Sailish Honap, et al.. (2025). Medical Therapy for Acute Severe Ulcerative Colitis: A Systematic Review With Meta-analysis. Clinical Gastroenterology and Hepatology. 23(13). 2376–2398.

Padley, James, et al.. (2025). Risankizumab is effective following ustekinumab failure in Crohn’s disease: A real-world study from a tertiary center. World Journal of Gastrointestinal Pharmacology and Therapeutics. 16(4). 110273–110273.

Clough, Jennifer, et al.. (2025). Role of Mirikizumab in the Treatment of Inflammatory Bowel Disease—From Bench to Bedside. Journal of Clinical Medicine. 14(3). 1001–1001. 6 indexed citations

Honap, Sailish, Vipul Jairath, Bruce E. Sands, et al.. (2024). Acute severe ulcerative colitis trials: the past, the present and the future. Gut. 73(10). 1763–1773. 23 indexed citations

Caron, Bénédicte, Damien Lœuille, Sailish Honap, et al.. (2024). Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 60(6). 686–700. 5 indexed citations

10.

Honap, Sailish, Nelly Agrinier, Silvio Danese, & Laurent Peyrin‐Biroulet. (2024). Disease prevention trials in IBD: feasibility to future outlook. Nature Reviews Gastroenterology & Hepatology. 22(1). 1–2. 1 indexed citations

11.

Dulai, Parambir S., Lauren C. Balmert, Laura E. Raffals, et al.. (2024). Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT‐UC Consortium. Alimentary Pharmacology & Therapeutics. 60(11-12). 1512–1524.

12.

Hall, Richard, Kamal Patel, Andrew Poullis, Richard Pollok, & Sailish Honap. (2024). Separating Infectious Proctitis from Inflammatory Bowel Disease—A Common Clinical Conundrum. Microorganisms. 12(12). 2395–2395. 1 indexed citations

13.

Honap, Sailish, Silvio Danese, Vipul Jairath, et al.. (2024). Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease?. Journal of Crohn s and Colitis. 19(2).

14.

Honap, Sailish, Bruce E. Sands, Vipul Jairath, et al.. (2024). Basket, Umbrella, and Platform Trials: The Potential for Master Protocol–Based Trials in Inflammatory Bowel Disease. Gastroenterology. 167(4). 636–642.e2. 12 indexed citations

15.

Honap, Sailish, et al.. (2024). Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies. Journal of Crohn s and Colitis. 18(Supplement_2). ii3–ii15. 37 indexed citations breakdown →

16.

Honap, Sailish, Anne Buisson, Silvio Danese, Laurent Beaugerie, & Laurent Peyrin‐Biroulet. (2023). Patient and Public Involvement in Research: Lessons for Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 17(11). 1882–1891. 11 indexed citations

17.

Honap, Sailish, Esha Sharma, Joel Mawdsley, et al.. (2022). P430 Longer-term tofacitinib effectiveness for the treatment of ulcerative colitis: Two-year outcomes from a UK observational cohort study. Journal of Crohn s and Colitis. 16(Supplement_1). i414–i415. 2 indexed citations

18.

Honap, Sailish, Gareth Parkes, Mark Samaan, et al.. (2021). P103 Ustekinumab: medium-term outcomes from a uk multi-centre real-world cohort. A94.2–A95. 1 indexed citations

19.

Honap, Sailish, Esha Sharma, Shuvra Ray, et al.. (2019). PTH-092 Early ‘Real World’ Experience with Tofacitinib for Moderate to Severe Ulcerative Colitis. A78.2–A79. 3 indexed citations

20.

Nedjadi, Taoufik, E Tweedle, Sarah Tonack, et al.. (2010). Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells. Carcinogenesis. 31(9). 1541–1551. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact